Acadia Healthcare (ACHC) Expected to Announce Quarterly Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) will likely be announcing its Q3 2025 results after the market closes on Wednesday, November 5th. Analysts expect Acadia Healthcare to post earnings of $0.71 per share and revenue of $852.4250 million for the quarter. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS.Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Thursday, November 6, 2025 at 9:00 AM ET.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. During the same quarter in the prior year, the firm posted $0.91 EPS. Acadia Healthcare’s quarterly revenue was up 9.2% compared to the same quarter last year. On average, analysts expect Acadia Healthcare to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Acadia Healthcare Stock Performance

ACHC stock opened at $23.17 on Wednesday. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The business’s fifty day simple moving average is $23.50 and its two-hundred day simple moving average is $22.95. Acadia Healthcare has a twelve month low of $17.13 and a twelve month high of $52.39. The firm has a market cap of $2.14 billion, a price-to-earnings ratio of 15.34, a PEG ratio of 4.55 and a beta of 0.90.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. EverSource Wealth Advisors LLC boosted its position in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Prudential Financial Inc. raised its stake in Acadia Healthcare by 21.9% during the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock valued at $225,000 after acquiring an additional 1,780 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Acadia Healthcare in the 2nd quarter valued at approximately $335,000. Corient Private Wealth LLC lifted its holdings in shares of Acadia Healthcare by 55.6% in the 2nd quarter. Corient Private Wealth LLC now owns 19,056 shares of the company’s stock valued at $432,000 after buying an additional 6,813 shares during the period. Finally, Bayesian Capital Management LP purchased a new position in Acadia Healthcare in the 2nd quarter valued at approximately $460,000.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ACHC. Cowen reaffirmed a “buy” rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. KeyCorp reduced their price objective on Acadia Healthcare from $55.00 to $35.00 and set an “overweight” rating for the company in a research note on Wednesday, October 8th. Raymond James Financial lifted their price target on Acadia Healthcare from $26.00 to $30.00 and gave the company an “outperform” rating in a research report on Friday, October 3rd. Mizuho dropped their price objective on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating on the stock in a report on Wednesday, August 13th. Finally, Barclays dropped their price objective on Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating on the stock in a report on Thursday, August 7th. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.09.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.